TET protein inhibitors: Potential and limitations
Author
Venhauerová, Anna
Novotný, Petr
Babula, Petr
Publication date
2023Published in
Biomedicine & PharmacotherapyVolume / Issue
166 (October)ISBN / ISSN
ISSN: 0753-3322ISBN / ISSN
eISSN: 1950-6007Metadata
Show full item recordCollections
This publication has a published version with DOI 10.1016/j.biopha.2023.115324
Abstract
TET proteins (methylcytosine dioxygenases) play an important role in the regulation of gene expression. Dysregulation of their activity is associated with many serious pathogenic states such as oncological diseases. Regulation of their activity by specific inhibitors could represent a promising therapeutic strategy. Therefore, this review describes various types of TET protein inhibitors in terms of their inhibitory mechanism and possible applicability. The potential and possible limitations of this approach are thoroughly discussed in the context of TET protein functionality in living systems. Furthermore, possible therapeutic strategies based on the inhibition of TET proteins are presented and evaluated, especially in the field of oncological diseases.
Keywords
TET protein, Inhibitor, Cancer, Therapy, Mitochondria
Permanent link
https://hdl.handle.net/20.500.14178/2055License
Full text of this result is licensed under: Creative Commons Uveďte původ 4.0 International